共 50 条
- [41] Quantitative analysis of the impact of deepness of response on survival time following patients with metastatic colorectal cancer treated by chemotherapy and anti-EGFR monoclonal antibodies.JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)Osumi, Hiroki论文数: 0 引用数: 0 h-index: 0机构: Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, JapanMatsusaka, Satoshi论文数: 0 引用数: 0 h-index: 0机构: Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, JapanSuenaga, Mitsukuni论文数: 0 引用数: 0 h-index: 0机构: Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, JapanWakatsuki, Takeru论文数: 0 引用数: 0 h-index: 0机构: Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, JapanOgura, Mariko论文数: 0 引用数: 0 h-index: 0机构: Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, JapanOzaka, Masato论文数: 0 引用数: 0 h-index: 0机构: Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, JapanShinozaki, Eiji论文数: 0 引用数: 0 h-index: 0机构: Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, JapanChin, Keisho论文数: 0 引用数: 0 h-index: 0机构: Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, JapanMizunuma, Nobuyuki论文数: 0 引用数: 0 h-index: 0机构: Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan
- [42] A novel predictive strategy by immunohistochemical analysis of four EGFR ligands in metastatic colorectal cancer treated with anti-EGFR antibodiesJournal of Cancer Research and Clinical Oncology, 2013, 139 : 367 - 378Michihiro Yoshida论文数: 0 引用数: 0 h-index: 0机构: Nagoya City University Graduate School of Medical Sciences,Department of Gastroenterology and MetabolismTakaya Shimura论文数: 0 引用数: 0 h-index: 0机构: Nagoya City University Graduate School of Medical Sciences,Department of Gastroenterology and MetabolismMikinori Sato论文数: 0 引用数: 0 h-index: 0机构: Nagoya City University Graduate School of Medical Sciences,Department of Gastroenterology and MetabolismMasahide Ebi论文数: 0 引用数: 0 h-index: 0机构: Nagoya City University Graduate School of Medical Sciences,Department of Gastroenterology and MetabolismTakahiro Nakazawa论文数: 0 引用数: 0 h-index: 0机构: Nagoya City University Graduate School of Medical Sciences,Department of Gastroenterology and MetabolismHiromitsu Takeyama论文数: 0 引用数: 0 h-index: 0机构: Nagoya City University Graduate School of Medical Sciences,Department of Gastroenterology and MetabolismTakashi Joh论文数: 0 引用数: 0 h-index: 0机构: Nagoya City University Graduate School of Medical Sciences,Department of Gastroenterology and Metabolism
- [43] Liquid biopsy-driven anti-EGFR rechallenge in patients with metastatic colorectal cancer.JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)Mariani, Stefano论文数: 0 引用数: 0 h-index: 0机构: Univ Cagliari, Cagliari, ItalyPuzzoni, Marco论文数: 0 引用数: 0 h-index: 0机构: Univ Cagliari, Cagliari, ItalyLiscia, Nicole论文数: 0 引用数: 0 h-index: 0机构: Univ Cagliari, Cagliari, ItalyImpera, Valentino论文数: 0 引用数: 0 h-index: 0机构: Univ Cagliari, Cagliari, ItalyPretta, Andrea论文数: 0 引用数: 0 h-index: 0机构: Univ Cagliari, Cagliari, ItalyTolu, Simona论文数: 0 引用数: 0 h-index: 0机构: Univ Cagliari, Cagliari, ItalyPireddu, Anna Grazia论文数: 0 引用数: 0 h-index: 0机构: Univ Cagliari, Cagliari, ItalyPersano, Mara论文数: 0 引用数: 0 h-index: 0机构: Univ Cagliari, Cagliari, ItalyMusio, Francesca论文数: 0 引用数: 0 h-index: 0机构: Univ Cagliari, Cagliari, ItalyDonisi, Clelia论文数: 0 引用数: 0 h-index: 0机构: Univ Cagliari, Cagliari, ItalyPinna, Giovanna论文数: 0 引用数: 0 h-index: 0机构: Univ Cagliari, Cagliari, ItalyLai, Eleonora论文数: 0 引用数: 0 h-index: 0机构: Univ Cagliari, Cagliari, ItalyDemurtas, Laura论文数: 0 引用数: 0 h-index: 0机构: Univ Cagliari, Cagliari, ItalyZiranu, Pina论文数: 0 引用数: 0 h-index: 0机构: Univ Cagliari, Cagliari, ItalyPusceddu, Valeria论文数: 0 引用数: 0 h-index: 0机构: Univ Cagliari, Cagliari, ItalyPisano, Marina论文数: 0 引用数: 0 h-index: 0机构: Univ Cagliari, Cagliari, ItalyPalomba, Grazia论文数: 0 引用数: 0 h-index: 0机构: Univ Cagliari, Cagliari, ItalyCasula, Milena论文数: 0 引用数: 0 h-index: 0机构: Univ Cagliari, Cagliari, ItalyPalmieri, Giuseppe论文数: 0 引用数: 0 h-index: 0机构: Univ Cagliari, Cagliari, ItalyScartozzi, Mario论文数: 0 引用数: 0 h-index: 0机构: Univ Cagliari, Cagliari, Italy
- [44] Anti-EGFR (cetuximab) combined with irinotecan for treatment of elderly patients with metastatic colorectal cancer (mCRC)Journal of Cancer Research and Clinical Oncology, 2012, 138 : 1487 - 1492S. Abdelwahab论文数: 0 引用数: 0 h-index: 0机构: Ain Shams University,Department of Clinical OncologyA. Azmy论文数: 0 引用数: 0 h-index: 0机构: Ain Shams University,Department of Clinical OncologyH. Abdel-aziz论文数: 0 引用数: 0 h-index: 0机构: Ain Shams University,Department of Clinical OncologyH. Salim论文数: 0 引用数: 0 h-index: 0机构: Ain Shams University,Department of Clinical OncologyA. Mahmoud论文数: 0 引用数: 0 h-index: 0机构: Ain Shams University,Department of Clinical Oncology
- [45] Nanofluidic digital PCR for improved selection of metastatic colorectal cancer patients to anti-EGFR therapiesEUROPEAN JOURNAL OF CANCER, 2013, 49 : S154 - S155Azuara, D.论文数: 0 引用数: 0 h-index: 0机构: Catalan Inst Oncol IDIBELL, Translat Res Lab, Lhospitalet De Llobregat, Spain Catalan Inst Oncol IDIBELL, Translat Res Lab, Lhospitalet De Llobregat, SpainSantos, C.论文数: 0 引用数: 0 h-index: 0机构: Catalan Inst Oncol IDIBELL, Translat Res Lab, Lhospitalet De Llobregat, Spain Catalan Inst Oncol IDIBELL, Dept Med Oncol, Lhospitalet De Llobregat, Spain Catalan Inst Oncol IDIBELL, Translat Res Lab, Lhospitalet De Llobregat, SpainLopez-Doriga, A.论文数: 0 引用数: 0 h-index: 0机构: Catalan Inst Oncol IDIBELL, Biomarkers & Susceptibil Unit, Lhospitalet De Llobregat, Spain Catalan Inst Oncol IDIBELL, Translat Res Lab, Lhospitalet De Llobregat, SpainMontal, R.论文数: 0 引用数: 0 h-index: 0机构: Catalan Inst Oncol IDIBELL, Translat Res Lab, Lhospitalet De Llobregat, Spain Catalan Inst Oncol IDIBELL, Dept Med Oncol, Lhospitalet De Llobregat, Spain Catalan Inst Oncol IDIBELL, Translat Res Lab, Lhospitalet De Llobregat, SpainSanjuan, X.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Bellvitge IDIBELL, Dept Pathol, Lhospitalet De Llobregat, Spain Catalan Inst Oncol IDIBELL, Translat Res Lab, Lhospitalet De Llobregat, SpainMoreno, V.论文数: 0 引用数: 0 h-index: 0机构: Catalan Inst Oncol IDIBELL, Biomarkers & Susceptibil Unit, Lhospitalet De Llobregat, Spain Catalan Inst Oncol IDIBELL, Translat Res Lab, Lhospitalet De Llobregat, SpainTabernero, J.论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Inst Oncol, Dept Med Oncol, Barcelona, Spain Catalan Inst Oncol IDIBELL, Translat Res Lab, Lhospitalet De Llobregat, SpainMontagut, C.论文数: 0 引用数: 0 h-index: 0机构: Hosp del Mar, Dept Med Oncol, Barcelona, Spain Catalan Inst Oncol IDIBELL, Translat Res Lab, Lhospitalet De Llobregat, SpainSalazar, R.论文数: 0 引用数: 0 h-index: 0机构: Catalan Inst Oncol IDIBELL, Translat Res Lab, Lhospitalet De Llobregat, Spain Catalan Inst Oncol IDIBELL, Dept Med Oncol, Lhospitalet De Llobregat, Spain Catalan Inst Oncol IDIBELL, Translat Res Lab, Lhospitalet De Llobregat, SpainCapella, G.论文数: 0 引用数: 0 h-index: 0机构: Catalan Inst Oncol IDIBELL, Translat Res Lab, Lhospitalet De Llobregat, Spain Catalan Inst Oncol IDIBELL, Translat Res Lab, Lhospitalet De Llobregat, Spain
- [46] Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR responseBMC CANCER, 2015, 15Liu, X.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USAGeorge, G. C.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USATsimberidou, A. M.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USANaing, A.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USAWheler, J. J.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USAKopetz, S.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Unit 426, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USAFu, S.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USAPiha-Paul, S. A.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USAEng, C.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Unit 426, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USAFalchook, G. S.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USAJanku, F.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USAGarrett, C.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Unit 426, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USAKarp, D.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USAKurzrock, R.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Diego, Moores Canc Ctr, Div Hematol & Oncol, San Diego, CA 92103 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USAZinner, R.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USARaghav, K.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Unit 426, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USASubbiah, V.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USAHess, K.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Biostat, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USAMeric-Bernstam, F.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USAHong, D. S.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USAOverman, M. J.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Unit 426, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Unit 455, Houston, TX 77030 USA
- [47] Retreatment With Anti-EGFR Antibodies in Metastatic Colorectal Cancer Patients: A Multi-institutional AnalysisCLINICAL COLORECTAL CANCER, 2020, 19 (03) : 191 - +Rossini, Daniele论文数: 0 引用数: 0 h-index: 0机构: Azienda Osped Univ Pisana, Dept Translat Res & New Technol Med & Surg, Unit Med Oncol 2, Pisa, Italy Azienda Osped Univ Pisana, Dept Translat Res & New Technol Med & Surg, Unit Med Oncol 2, Pisa, ItalyGermani, Marco Maria论文数: 0 引用数: 0 h-index: 0机构: Azienda Osped Univ Pisana, Dept Translat Res & New Technol Med & Surg, Unit Med Oncol 2, Pisa, Italy Azienda Osped Univ Pisana, Dept Translat Res & New Technol Med & Surg, Unit Med Oncol 2, Pisa, ItalyPagani, Filippo论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Med Oncol Dept, Milan, Italy Azienda Osped Univ Pisana, Dept Translat Res & New Technol Med & Surg, Unit Med Oncol 2, Pisa, ItalyPellino, Antonio论文数: 0 引用数: 0 h-index: 0机构: Univ Padua, Dept Surg Oncol & Gastroenterol, Veneto Inst Oncol, IOV IRCCS,Dept Clin & Expt Oncol,Unit Med Oncol 1, Padua, Italy Azienda Osped Univ Pisana, Dept Translat Res & New Technol Med & Surg, Unit Med Oncol 2, Pisa, ItalyDell'Aquila, Emanuela论文数: 0 引用数: 0 h-index: 0机构: Univ Rome, Dept Med Oncol, Campus Biomed, Rome, Italy Azienda Osped Univ Pisana, Dept Translat Res & New Technol Med & Surg, Unit Med Oncol 2, Pisa, ItalyBensi, Maria论文数: 0 引用数: 0 h-index: 0机构: Fdn Policlin Univ A Gemelli, IRCCS UOC Oncol Med, Rome, Italy Azienda Osped Univ Pisana, Dept Translat Res & New Technol Med & Surg, Unit Med Oncol 2, Pisa, ItalyLiscia, Nicole论文数: 0 引用数: 0 h-index: 0机构: Univ Cagliari, Univ Hosp, Med Oncol Dept, Cagliari, Italy Azienda Osped Univ Pisana, Dept Translat Res & New Technol Med & Surg, Unit Med Oncol 2, Pisa, ItalyMoretto, Roberto论文数: 0 引用数: 0 h-index: 0机构: Azienda Osped Univ Pisana, Dept Translat Res & New Technol Med & Surg, Unit Med Oncol 2, Pisa, Italy Azienda Osped Univ Pisana, Dept Translat Res & New Technol Med & Surg, Unit Med Oncol 2, Pisa, ItalyBoccaccino, Alessandra论文数: 0 引用数: 0 h-index: 0机构: Azienda Osped Univ Pisana, Dept Translat Res & New Technol Med & Surg, Unit Med Oncol 2, Pisa, Italy Azienda Osped Univ Pisana, Dept Translat Res & New Technol Med & Surg, Unit Med Oncol 2, Pisa, ItalyPrisciandaro, Michele论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Med Oncol Dept, Milan, Italy Azienda Osped Univ Pisana, Dept Translat Res & New Technol Med & Surg, Unit Med Oncol 2, Pisa, ItalyManglaviti, Sara论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Med Oncol Dept, Milan, Italy Azienda Osped Univ Pisana, Dept Translat Res & New Technol Med & Surg, Unit Med Oncol 2, Pisa, ItalySchirripa, Marta论文数: 0 引用数: 0 h-index: 0机构: IOV IRCCS, Dept Clin & Expt Oncol, Unit Med Oncol 1, Veneto Inst Oncol, Padua, Italy Azienda Osped Univ Pisana, Dept Translat Res & New Technol Med & Surg, Unit Med Oncol 2, Pisa, ItalyVivolo, Raffaella论文数: 0 引用数: 0 h-index: 0机构: Fdn Policlin Univ A Gemelli, IRCCS UOC Oncol Med, Rome, Italy Azienda Osped Univ Pisana, Dept Translat Res & New Technol Med & Surg, Unit Med Oncol 2, Pisa, ItalyScartozzi, Mario论文数: 0 引用数: 0 h-index: 0机构: Univ Cagliari, Univ Hosp, Med Oncol Dept, Cagliari, Italy Azienda Osped Univ Pisana, Dept Translat Res & New Technol Med & Surg, Unit Med Oncol 2, Pisa, ItalySantini, Daniele论文数: 0 引用数: 0 h-index: 0机构: Univ Rome, Dept Med Oncol, Campus Biomed, Rome, Italy Azienda Osped Univ Pisana, Dept Translat Res & New Technol Med & Surg, Unit Med Oncol 2, Pisa, ItalySalvatore, Lisa论文数: 0 引用数: 0 h-index: 0机构: Fdn Policlin Univ A Gemelli, IRCCS UOC Oncol Med, Rome, Italy Azienda Osped Univ Pisana, Dept Translat Res & New Technol Med & Surg, Unit Med Oncol 2, Pisa, ItalyPietrantonio, Filippo论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ist Nazl Tumori, Med Oncol Dept, Milan, Italy Azienda Osped Univ Pisana, Dept Translat Res & New Technol Med & Surg, Unit Med Oncol 2, Pisa, ItalyLoupakis, Fotios论文数: 0 引用数: 0 h-index: 0机构: IOV IRCCS, Dept Clin & Expt Oncol, Unit Med Oncol 1, Veneto Inst Oncol, Padua, Italy Azienda Osped Univ Pisana, Dept Translat Res & New Technol Med & Surg, Unit Med Oncol 2, Pisa, ItalyFalcone, Alfredo论文数: 0 引用数: 0 h-index: 0机构: Azienda Osped Univ Pisana, Dept Translat Res & New Technol Med & Surg, Unit Med Oncol 2, Pisa, Italy Azienda Osped Univ Pisana, Dept Translat Res & New Technol Med & Surg, Unit Med Oncol 2, Pisa, ItalyCremolini, Chiara论文数: 0 引用数: 0 h-index: 0机构: Azienda Osped Univ Pisana, Dept Translat Res & New Technol Med & Surg, Unit Med Oncol 2, Pisa, Italy Azienda Osped Univ Pisana, Dept Translat Res & New Technol Med & Surg, Unit Med Oncol 2, Pisa, Italy
- [48] Anti-EGFR (cetuximab) combined with irinotecan for treatment of elderly patients with metastatic colorectal cancer (mCRC)JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (09) : 1487 - 1492Abdelwahab, S.论文数: 0 引用数: 0 h-index: 0机构: Ain Shams Univ, Dept Clin Oncol, Nasr City 11371, Cairo, Egypt Ain Shams Univ, Dept Clin Oncol, Nasr City 11371, Cairo, EgyptAzmy, A.论文数: 0 引用数: 0 h-index: 0机构: Ain Shams Univ, Dept Clin Oncol, Nasr City 11371, Cairo, Egypt Ain Shams Univ, Dept Clin Oncol, Nasr City 11371, Cairo, EgyptAbdel-aziz, H.论文数: 0 引用数: 0 h-index: 0机构: Ain Shams Univ, Dept Clin Oncol, Nasr City 11371, Cairo, Egypt Ain Shams Univ, Dept Clin Oncol, Nasr City 11371, Cairo, EgyptSalim, H.论文数: 0 引用数: 0 h-index: 0机构: Ain Shams Univ, Dept Clin Oncol, Nasr City 11371, Cairo, Egypt Ain Shams Univ, Dept Clin Oncol, Nasr City 11371, Cairo, Egypt论文数: 引用数: h-index:机构:
- [49] Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR responseBMC Cancer, 15X. Liu论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program)G. C. George论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program)A. M. Tsimberidou论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program)A. Naing论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program)J. J. Wheler论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program)S. Kopetz论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program)S. Fu论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program)S. A. Piha-Paul论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program)C. Eng论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program)G. S. Falchook论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program)F. Janku论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program)C. Garrett论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program)D. Karp论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program)R. Kurzrock论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program)R. Zinner论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program)K. Raghav论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program)V. Subbiah论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program)K. Hess论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program)F. Meric-Bernstam论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program)D. S. Hong论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program)M. J. Overman论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Investigational Cancer Therapeutics (Phase 1 Clinical Trials Program)
- [50] Prognostic role of ERBB2, MET and VEGFA expression in metastatic colorectal cancer patients treated with anti-EGFR antibodiesBritish Journal of Cancer, 2016, 114 : 1003 - 1011Naoki Takahashi论文数: 0 引用数: 0 h-index: 0机构: National Cancer Center Hospital,Gastrointestinal Medical Oncology DivisionSatoru Iwasa论文数: 0 引用数: 0 h-index: 0机构: National Cancer Center Hospital,Gastrointestinal Medical Oncology DivisionHirokazu Taniguchi论文数: 0 引用数: 0 h-index: 0机构: National Cancer Center Hospital,Gastrointestinal Medical Oncology DivisionYusuke Sasaki论文数: 0 引用数: 0 h-index: 0机构: National Cancer Center Hospital,Gastrointestinal Medical Oncology DivisionHirokazu Shoji论文数: 0 引用数: 0 h-index: 0机构: National Cancer Center Hospital,Gastrointestinal Medical Oncology DivisionYoshitaka Honma论文数: 0 引用数: 0 h-index: 0机构: National Cancer Center Hospital,Gastrointestinal Medical Oncology DivisionAtsuo Takashima论文数: 0 引用数: 0 h-index: 0机构: National Cancer Center Hospital,Gastrointestinal Medical Oncology DivisionNatsuko Okita论文数: 0 引用数: 0 h-index: 0机构: National Cancer Center Hospital,Gastrointestinal Medical Oncology DivisionKen Kato论文数: 0 引用数: 0 h-index: 0机构: National Cancer Center Hospital,Gastrointestinal Medical Oncology DivisionTetsuya Hamaguchi论文数: 0 引用数: 0 h-index: 0机构: National Cancer Center Hospital,Gastrointestinal Medical Oncology DivisionYasuhiro Shimada论文数: 0 引用数: 0 h-index: 0机构: National Cancer Center Hospital,Gastrointestinal Medical Oncology DivisionYasuhide Yamada论文数: 0 引用数: 0 h-index: 0机构: National Cancer Center Hospital,Gastrointestinal Medical Oncology Division